Allergy and Immunology · North Port, FL
NPI
1174941645
Since 2014
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2565 N Toledo Blade Blvd
North Port, FL, 34289
Phone (941) 257-3119
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
4,217 services
Medicare patients, 2024
131
Average age 72
Drug cost, 2024
$785K
493 prescriptions
Company payments, 2025
$35K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nilamben Patel was code 95004 (test - miscellaneous), 3,134 times for 48 patients. In total Nilamben Patel billed 4,217 services in 22 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 3,134 | 48 | $2.81 | $8,812 |
| 95165 Treatment - Miscellaneous | Office | 276 | 21 | $10.81 | $2,984 |
| 95117 Treatment - Miscellaneous | Office | 239 | 21 | $7.96 | $1,901 |
| 99213 Office E&M - Established | Office | 84 | 53 | $66.64 | $5,598 |
| 99203 Office E&M - New | Office | 44 | 44 | $84.82 | $3,732 |
| 99204 Office E&M - New | Office | 38 | 38 | $116.84 | $4,440 |
| 99214 Office E&M - Established | Office | 38 | 34 | $99.12 | $3,767 |
By year: 2022 $22K for 2,556 services; 2023 $38K for 4,580 services; 2024 $35K for 4,217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nilamben Patel prescribed most often to Medicare patients was Hyqvia (Igg/Hyaluronidase,recombinant), with 62 prescriptions and refills. In total Nilamben Patel wrote 493 Medicare prescriptions that cost $785K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hyqvia Igg/Hyaluronidase,recombinant | 62 | 62 | Under 11 | $386K |
| Ipratropium Bromide Generic | 60 | 75 | 32 | $1,480 |
| Azelastine Hcl Generic | 59 | 93 | 18 | $1,040 |
| Levocetirizine Dihydrochloride Generic | 43 | 68 | Under 11 | $588 |
| Dupixent Pen Dupilumab | 32 | 32 | Under 11 | $181K |
| Montelukast Sodium Generic | 24 | 62 | Under 11 | $118 |
| Prednisone Generic | 23 | 26 | 18 | $54.37 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 14 | 18 | Under 11 | $11K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 13 | 13 | Under 11 | $91K |
| Symbicort Budesonide/Formoterol Fumarate | 11 | 11 | Under 11 | $2,522 |
Brand drugs: 219 claims; generic drugs: 274 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nilamben Patel $35K ($35K in general payments such as food, travel and fees) from 13 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 54 | $23K |
| Novartis Pharmaceuticals Corporation NVS | 14 | $6,977 |
| Genzyme Corporation SNY | 14 | $3,883 |
| CSL Behring CSL.AX | 15 | $382 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $196 |
| GlaxoSmithKline, LLC. GSK | 10 | $157 |
| Lilly USA, LLC LLY | 2 | $57.92 |
| BioCryst US Sales Co., LLC | 3 | $51.9 |
| Grifols USA, LLC | 2 | $44.16 |
| Ionis Pharmaceuticals, Inc. IONS | 2 | $36.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.